Healthcare Sales & Marketing Network News: TELCYTA

Searching News Database: TELCYTA

HSMN NewsFeed - 5 Aug 2008
Telik Names Stefan Ryser, Ph.D. Senior Vice President, Corporate Strategy
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2007
FDA Removes Partial Hold on TELCYTA Clinical Development
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 Jun 2007
FDA Converts TELCYTA Full Clinical Hold to Partial Hold
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 3 Jun 2007
Telik Reports Results of TELCYTA(R) Assist-3 Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
Telik Announces Top-Line Results of TELCYTA(R) ASSIST-2 Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 3 Jun 2007
Telik Reports Results of TELCYTA(R) ASSIST-1 Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Apr 2007
Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of TELCYTA as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer
Biopharmacetuicals Oncology

HSMN NewsFeed - 8 Feb 2007
SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Dec 2006
Telik Reports Preliminary Results on ASSIST-1, ASSIST-2 and ASSIST-3 Phase 3 Clinical Trials
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Sep 2006
Telik Updates ASSIST-1 Status
Biopharmaceuticals Oncology

Return to NewsFeed

Additional items found! 29

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 29 additional stories matching:
TELCYTA
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.